Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?Tracleer online pharmacy?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Complera manufacturer?Are there income restrictions for lipitor's patient program?
See the DrugPatentWatch profile for Qelbree
FDA approval date: April 30, 2021. It was approved for the treatment of ADHD in pediatric patients aged 6 to 17 (viloxazine hydrochloride ER, brand name Qelbree, by Supernus Pharmaceuticals). If you want, I can add details about other indications or any label updates since then.
Other Questions About Qelbree :